Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide

Infection and Immunity

Volumn 67, Issue 11, 1999, Pages 6084-6089

  Bals, Robert ^a   Weiner, Daniel J ^a,b   Moscioni, A David ^a   Meegalla, Rupalie L ^a   Wilson, James M ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; COMPLEMENTARY DNA; DEFENSIN; GALACTOSAMINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNE RESPONSE; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPSIS; VIRUS RECOMBINANT;

EID: 0032708355     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.11.6084-6089.1999     Document Type: Article

References (23)

1. Agerberth, B., H. Gunne, J. Odeberg, P. Kogner, H. G. Boman, and G. H. Gudmundsson. 1995. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92:195-199.
2. Bals, R., X. Wang, Z. Wu, T. Freeman, V. Banfa, M. Zasloff, and J. M. Wilson. 1998. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J. Clin. Investig. 102:874-880.
3. Bals, R., X. Wang, M. Zasloff, and J. M. Wilson. 1998. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA 95:9541-9546.
4. Benseh, K. W., M. Raida, H.-J. Magert, P. Schulz-Knappe, and W.-G. Forssmann. 1995. hBD-1: a novel β-defensin from human plasma. FEBS Lett. 368:331-335.
5. Engelhardt, J. F., Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson. 1993. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with El-deleted adenoviruses. Nat. Genet. 4:27-34.
6. Fearon, D., and R. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science 272:50-54.
7. Fenton, M., and D. Golenbock. 1998. LPS-binding proteins and receptors. J. Leukoc. Biol. 64:25-32.
8. Fletcher, M., M. Kloczewiak, P. Loiselle, M. Ogata, M. Vermeulen, E. Zanzot, and H. Warren. 1997. A novel peptide-IgG conjugate, CAP18(106-138)-IgI, that binds and neutralizes endotoxin and kills gram-negative bacteria. J. Infect. Dis. 175:621-632.
9. Frohm, M., B. Agerberth, G. Ahangari, M. Stahle-Backdahl, S. Liden, H. Wigzell, and G. H. Gudmundsson. 1997. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272:15258-15263.
10. Frohm, M., H. Gunne, A.-C. Bergman, B. Agerberth, T. Bergman, A. Boman, S. Liden, H. Jornvall, and H. Boman. 1996. Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237:86-92.
11. Giroir, B., P. Quint, P. Barton, E. Kirsch, L. Kitchen, B. Goldstein, B. Nelson, N. Wedel, S. Carroll, and P. Scanon. 1997. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningicoccal sepsis. Lancet 350: 1439-1442.
12. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Karl, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
13. Gudmundsson, G. H., B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238:325-332.
14. Harder, J., J. Bartels, E. Christophers, and J.-M. Schroeder. 1997. A peptide antibiotic from human skin. Nature 387:861.
15. Johnson, J., and J. Brown. 1996. Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid vesicoureteral reflux yet produce bladder infection. J. Infect. Dis. 173:746-749.
16. Kirikae, T., M. Hirata, H. Yamasu, F. Kirikae, H. Tamura, F. Kayama, K. Nakatsuka, T. Yokochi, and M. Nakano. 1998. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66:1861-1868.
17. Larrick, J., M. Hirata, R. Balint, J. Lee, J. Zhong, and S. Wright. 1995. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63:1291-1297.
18. Lehrer, R., and T. Ganz. 1999. Antimicrobial peptides in mammalian and insect host defense. Curr. Opin. Immunol. 11:23-27.
19. Lehrer, R., T. Ganz, and M. Selsted. 1991. Defensins: endogenous antibiotic peptides of animal cells. Cell 64:229-230.
20. Sorensen, O., K. Arnljots, J. B. Cowland, D. F. Bainton, and N. Borregaard. 1997. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796-2803.
21. Turner, J., Y. Cho, N.-N. Dinh, A. Waring, and R. Lehrer. 1998. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents. Chemother. 42:2206-2214.
22. Wang, Y., B. Agerberth, A. Lothgren, A. Almstedt, and J. Johansson. 1998. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273:33115-33118.
23. Zanetti, M., R. Gennaro, and D. Romeo. 1995. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374:1-5.